ReviewPathol Res Pract2023
STAT3 signaling in pancreatic ductal adenocarcinoma: a candidate therapeutic target.
- Journal
- Pathol Res Pract
- Published
- 24 March 2023
- Citations
- 15
- Type
- Review
These are the paper’s bibliographic details. A summary of its population, design, endpoints and findings, each tied to a quote, has not been written for this paper yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.
Try
Source text
abstract license unknown
Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive cancer with a poor prognosis which is lethal in over 90% of cases despite the standard therapies. Mainly activated by Janus kinase 2 (JAK2), signal transducer and activator of transcription 3 (STAT3) is a key transcription factor, capable of exerting the expression of multitude of genes involved in survival. … Excerpt only: this text is the publisher’s. Read it in full at the source.